Skip to content

Opus Genetics, Inc.: 10-Q filed 2018-08-03

What Opus Genetics, Inc. reported in its quarterly report filed 2018-08-03 (fiscal Q2 2018): 27 published measures, 77 facts as tagged in accession 0001140361-18-035394.

This filing

Form
10-Q (quarterly report)
Filed
2018-08-03
Fiscal period
fiscal Q2 2018
Accession
0001140361-18-035394 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Opus Genetics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-3018,235,971USD
At 2017-12-3128,287,881USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-06-306,812,707USD
At 2017-12-3111,519,285USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-06-3011,423,264USD
At 2017-12-3116,768,596USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-305,094,275USD
At 2017-12-318,899,154USD
At 2017-06-308,790,519USD
At 2016-12-3111,578,473USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-3,838,268USD91
2018-01-01 to 2018-06-30-5,913,141USD181
2017-04-01 to 2017-06-30947,056USD91
2017-01-01 to 2017-06-30-20,663,968USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-06-30-10,051,386USD181
2017-01-01 to 2017-06-30-8,267,979USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-06-3014,786,595USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-06-306,246,507USD181
2017-01-01 to 2017-06-30-9,306,570USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-06-30-146,231,853USD
At 2017-12-31-140,318,712USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-04-01 to 2018-06-3031,744,439shares91
2018-01-01 to 2018-06-3031,737,998shares181
2017-04-01 to 2017-06-3026,001,797shares91
2017-01-01 to 2017-06-3024,932,705shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-04-01 to 2018-06-3031,744,439shares91
2018-01-01 to 2018-06-3031,737,998shares181
2017-04-01 to 2017-06-3028,265,440shares91
2017-01-01 to 2017-06-3024,932,705shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-0.12USD/shares91
2018-01-01 to 2018-06-30-0.19USD/shares181
2017-04-01 to 2017-06-300.04USD/shares91
2017-01-01 to 2017-06-30-0.83USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-0.12USD/shares91
2018-01-01 to 2018-06-30-0.19USD/shares181
2017-04-01 to 2017-06-300.03USD/shares91
2017-01-01 to 2017-06-30-0.83USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-06-3097,765USD
At 2017-12-31121,460USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-06-30563,728USD181
2017-01-01 to 2017-06-30562,392USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-5,001,441USD91
2018-01-01 to 2018-06-30-10,887,296USD181
2017-04-01 to 2017-06-30-4,283,925USD91
2017-01-01 to 2017-06-30-8,237,166USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-3018,107,421USD
At 2017-12-3128,135,636USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-04-01 to 2018-06-305,001,441USD91
2018-01-01 to 2018-06-3010,887,296USD181
2017-04-01 to 2017-06-304,283,925USD91
2017-01-01 to 2017-06-308,237,166USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-04-01 to 2018-06-303,432,593USD91
2018-01-01 to 2018-06-307,491,126USD181
2017-04-01 to 2017-06-302,544,262USD91
2017-01-01 to 2017-06-304,806,657USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-06-3031,744,439shares
At 2017-12-3131,725,114shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-06-30-64,955USD
At 2017-12-31-56,886USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-06-30785,858USD
At 2017-12-31833,306USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-06-30688,093USD
At 2017-12-31711,846USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-06-301,365,778USD
At 2017-12-311,304,541USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-3,813,847USD91
2018-01-01 to 2018-06-30-5,921,210USD181
2017-04-01 to 2017-06-30927,677USD91
2017-01-01 to 2017-06-30-20,683,551USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,568,848USD91
2018-01-01 to 2018-06-303,396,170USD181
2017-04-01 to 2017-06-301,739,663USD91
2017-01-01 to 2017-06-303,430,509USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-04-01 to 2018-06-301,163,173USD91
2018-01-01 to 2018-06-304,974,155USD181
2017-04-01 to 2017-06-305,230,981USD91
2017-01-01 to 2017-06-30-12,426,802USD181

Inspect the source

Entity
Opus Genetics, Inc. / CIK 0001228627
Captured
2026-09-20T07:46:24.028Z
SEC response SHA-256
59b3f548361fa5c66fb8bd927bac9bc7dc8822bcce158860c7c4d77974af0a92

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001228627.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))